We hypothesize that reduced phagocytic capacity of the endogenous microglial system during aging elevates the risk of AD, but that this is rescued in CHIP carriers, possibly due to the influx of peripherally derived myeloid cells into the brain parenchyma, which are able to outcompete endogenous MG. The gene discussed is STUB1; the disease is Alzheimer disease.